Position in FATE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$951,008
-$109,539 QoQ
Shares Held
352,226
-60.1% QoQ
Ownership
0.294%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 156 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 59%
Shared 18%
None 23%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. FATE ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $951,008 | 352,226 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,060,547 | 883,790 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,545,926 | 1,577,478 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,639,667 | 2,094,975 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,730,254 | 2,437,729 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,047,330 | 2,591,558 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,782,320 | 2,898,377 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,166,558 | 2,619,017 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,987,316 | 2,130,280 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,803,732 | 1,063,179 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,199,691 | 320,774 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,516,113 | 715,149 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $974,494 | 204,726 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,992,313 | 349,529 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,564,319 | 551,469 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $5,371,272 | 239,682 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,620,371 | 267,166 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,086,027 | 389,116 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $24,251,049 | 414,477 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $18,911,219 | 319,069 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,114,761 | 128,065 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $5,339,626 | 64,762 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,942,312 | 32,358 | Shares | Defined | 2021-03-08 | |
| 2020-06-30 | $781,273 | 22,771 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $505,743 | 22,771 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||